Answers are grounded in this paper and cite their sources.
The management of nevoid basal-cell carcinomas in this syndrome is sometimes very difficult, because of the high number of tumors and of their particular localizations. The authors reviewed the literature and here report their experience in the treatment of nevoid basal-cell carcinoma syndrome with aromatic retinoid etretinate (RO 10-9359; Tigason).
No takes yet. Share an insight, caveat, or question.
Cristofolini et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: